Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS
NSE
60.16
1.39 (2.37%)
Prev Close
58.77
Open Price
58.77
Volume
13,747
Today Low / High
57.5 / 60.9
52 WK Low / High
32.85 / 74.8
Range
57 - 63
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 60.16, with a change of 1.39 (2.36515%). The expected target range on the NSE is between 57 - 63. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
22 Aug
64.00
1.78%
21 Aug
64.25
0.47%
20 Aug
65.10
-0.03%
19 Aug
64.36
2.08%
18 Aug
65.80
-0.49%
14 Aug
64.51
2.00%
13 Aug
63.55
1.51%
12 Aug
65.89
-0.15%
11 Aug
66.84
-1.42%
08 Aug
65.76
1.64%
07 Aug
67.00
1.90%
06 Aug
70.01
-2.19%
05 Aug
66.50
5.28%
04 Aug
68.00
1.19%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 60.16, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 60.16 | 60.76 | 54.69 - 66.84 |
| 61.36 | 49.09 - 73.64 | ||
| 61.96 | 43.38 - 80.55 | ||
| Bearish Scenario | 60.16 | 59.56 | 53.60 - 65.51 |
| 58.96 | 47.17 - 70.75 | ||
| 58.36 | 40.85 - 75.86 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
50,621
Market Cap
1,846,999,102
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
108.37
DCF
-44
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 473.94 Cr | 464.81 Cr | 9.13 Cr | 0.0193 | 0.00 Cr | 0.00 Cr | 0.31 Cr | 4.02 Cr | 1.43 | 12.06 Cr | 0.0085 |
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 414.25 Cr | 403.84 Cr | 10.41 Cr | 0.0251 | 0.00 Cr | 0.88 Cr | 6.69 Cr | 3.77 Cr | 1.49 | 8.27 Cr | 0.0091 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 10.03 Cr | 6.55 Cr | 2.72 | 12.01 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 8.23 Cr | 6.51 Cr | 2.79 | 9.15 Cr | 0.0187 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 238.27 Cr | 99.79 Cr | 138.4805 Cr | 34.86 Cr | 33.38 Cr | 45.48 Cr | 16.22 Cr | 0.00 Cr | 0.00 Cr | 8.76 Cr | 96.8804 Cr |
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 28.82 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 0.41 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 13.68 Cr | 14.47 Cr | 5.23 Cr | -3.34 Cr | 2.80 Cr | 130.0762 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 18.46 Cr | 14.26 Cr | 4.25 Cr | 0.00 Cr | 0.40 Cr | 132.6120 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.8948 Cr | -5.9394 Cr | 4.9237 Cr | -4.3096 Cr | 0.0000 Cr | 1.4733 Cr | -5.2044 Cr | 4.0239 Cr | 3.2337 Cr | 0.0000 Cr | -10.8045 Cr |
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 6.2319 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | 0.0000 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 108.10 Cr | 108.02 Cr | 0.08 Cr | 0.0007 | -3.43 Cr | 0.47 Cr | 0.17 | 2.69 Cr | 0.0043 |
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
| 2024-09-30 | 105.14 Cr | 98.90 Cr | 6.24 Cr | 0.0594 | 3.23 Cr | 1.60 Cr | 0.57 | 3.74 Cr | 0.0152 |
| 2024-06-30 | 126.91 Cr | 123.59 Cr | 3.32 Cr | 0.0261 | 2.58 Cr | 1.24 Cr | 0.44 | 2.75 Cr | 0.0098 |
| 2024-03-31 | 210.35 Cr | 206.75 Cr | 3.60 Cr | 0.0171 | -1.84 Cr | 2.15 Cr | 0.77 | 3.70 Cr | 0.0102 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 0.00 Cr | 1.47 Cr | 159.55 Cr | 45.48 Cr | 213.28 Cr | 16.22 Cr | 238.27 Cr | 99.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -135.59 Cr |
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 23.52 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | -132.77 Cr |
| 2024-03-31 | 1.59 Cr | 1.30 Cr | 1.59 Cr | 200.85 Cr | 34.68 Cr | 282.60 Cr | 14.66 Cr | 304.99 Cr | 172.22 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.02 Cr | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.94 Cr | 2.11 Cr | 1.17 Cr | 0.00 Cr | 0.94 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,594.50 | ₹3,825,651,960,000.00 | ₹3,176,398.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,131.50 | ₹1,627,723,173,500.00 | ₹283,785.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,559.80 | ₹1,204,796,511,000.00 | ₹279,286.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,260.10 | ₹1,048,821,647,708.00 | ₹2,422,548.00 |
| Mankind Pharma Limited | MANKIND | ₹2,471.40 | ₹1,020,017,857,464.00 | ₹330,123.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹981.05 | ₹987,161,941,500.00 | ₹833,099.00 |
| Lupin Limited | LUPIN | ₹1,894.90 | ₹865,489,890,300.00 | ₹865,948.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,303.50 | ₹634,112,977,500.00 | ₹115,288.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,027.90 | ₹597,006,375,800.00 | ₹882,146.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,923.90 | ₹542,926,503,900.00 | ₹239,911.00 |
| Laurus Labs Limited | LAURUSLABS | ₹856.90 | ₹462,576,042,500.00 | ₹646,760.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,384.40 | ₹351,227,817,600.00 | ₹156,593.00 |
| Cohance Lifesciences Limited | COHANCE | ₹880.60 | ₹336,888,507,245.00 | ₹1,169,434.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,477.60 | ₹309,541,433,600.00 | ₹351,051.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,724.30 | ₹269,777,080,800.00 | ₹145,222.00 |
| Piramal Enterprises Limited | PEL | ₹1,120.20 | ₹253,924,695,600.00 | ₹278,603.00 |
| Eris Lifesciences Limited | ERIS | ₹1,800.20 | ₹245,199,841,400.00 | ₹83,216.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,427.50 | ₹231,938,772,500.00 | ₹151,684.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,460.50 | ₹211,512,500,000.00 | ₹24,461.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹936.95 | ₹184,169,702,850.00 | ₹67,299.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,455.00 | ₹172,626,304,500.00 | ₹35,910.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,023.10 | ₹162,960,391,100.00 | ₹233,835.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,098.60 | ₹159,518,153,620.00 | ₹50,666.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹862.00 | ₹154,392,820,000.00 | ₹244,250.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹492.25 | ₹119,441,509,000.00 | ₹16,943,211.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,370.00 | ₹105,738,178,000.00 | ₹67,162.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹846.25 | ₹82,755,549,125.00 | ₹49,736.00 |
| Strides Pharma Science Limited | STAR | ₹863.70 | ₹79,609,560,990.00 | ₹260,707.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹841.35 | ₹76,255,437,537.00 | ₹184,206.00 |
| FDC Limited | FDC | ₹457.75 | ₹74,526,277,500.00 | ₹68,837.00 |
| Innova Captab Limited | INNOVACAP | ₹902.05 | ₹51,619,748,107.00 | ₹28,678.00 |
| Suven Life Sciences Limited | SUVEN | ₹213.95 | ₹46,656,932,300.00 | ₹128,736.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹140.09 | ₹45,462,286,980.00 | ₹139,730.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹469.55 | ₹42,855,828,500.00 | ₹82,923.00 |
| Sequent Scientific Limited | SEQUENT | ₹169.37 | ₹42,399,238,950.00 | ₹192,650.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,320.50 | ₹38,378,749,500.00 | ₹9,390.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹734.05 | ₹37,230,355,355.00 | ₹30,648.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹366.95 | ₹36,797,012,100.00 | ₹35,409.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹503.80 | ₹35,470,442,040.00 | ₹10,456.00 |
| Hikal Limited | HIKAL | ₹255.00 | ₹31,441,755,000.00 | ₹275,117.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹612.95 | ₹29,515,381,350.00 | ₹45,262.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹90.74 | ₹26,634,639,980.00 | ₹528,939.00 |
| Alembic Limited | ALEMBICLTD | ₹101.53 | ₹26,071,076,358.00 | ₹157,122.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹46.63 | ₹25,551,095,020.00 | ₹2,400,816.00 |
Key Executives
Chief Accountant
Mr. A. S. Kathawala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Mr. Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mr. Mihir Rajesh Ghatalia B.E
Gender: male
Year Born: 1983
Chief Financial Officer
Ms. Mira Mihir Ghatalia
Gender: female
Year Born:
Executive Director
Mr. Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mihir Rajesh Ghatalia.
What is the current market price of the stock?
The current price is ₹65.14.
What is the 52-week price range?
The range is ₹32.85-74.8.
What is the market capitalization of the company?
The market capitalization is ₹184.70 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 45.42.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹184.70 crores and an average daily volume of 50,621 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.